Preventive Medicine and Quality Management Department, Hospital General Universitario Gregorio Marañón, C / Doctor Esquerdo, 46-28007 Madrid, Spain.
Eur J Intern Med. 2012 Dec;23(8):696-700. doi: 10.1016/j.ejim.2012.08.013. Epub 2012 Sep 27.
Medication reconciliation process has proved to be an effective tool to improve the safety of drug use. The objective of this study was to assess the impact of an intervention aimed to decrease unintended discrepancies between patient's usual treatment and medications prescribed on admission to the Department of Internal Medicine.
A quasi-experimental study was carried out from June 2009 to May 2010, analyzing discrepancies between home medication and drugs prescribed in a tertiary care hospital, before (first phase) and after (second phase) an electronic reconciliation tool was introduced at admission. This tool connected patients' usual medication with the electronic prescription program. The research team was made up of two hospital pharmacists, two nurses and three physicians from the Internal and Preventive Medicine Departments.
During the two phases of the study, 162 patients were included with a total of 1,959 medicines reconciled. The incidence of unintended discrepancies decreased from 3.5% to 1.8% after the intervention (p value 0.03). The proportion of patients with at least one unintended discrepancy was 23.7% in the first phase and 14.6% in the second phase (p value 0.20). Omission was the most common unintended discrepancy. Asthmatic patients showed 6 times higher risk of being affected by an unintended discrepancy (OR 6.37, 95%CI 1.6-25.5; p value 0.009).
Implementing a computerized tool integrated into the electronic prescribing program could be very helpful to develop a medication reconciliation process. It is essential to involve all hospital staff in this process.
药物重整过程已被证明是提高用药安全性的有效工具。本研究的目的是评估一项旨在减少内科患者入院时患者常规治疗与医嘱之间无意差异的干预措施的效果。
这是一项从 2009 年 6 月至 2010 年 5 月进行的准实验研究,分析了三级保健医院中患者家庭用药与入院时开具的药物之间的差异,在此之前(第一阶段)和之后(第二阶段)引入电子重整工具。该工具将患者的常规用药与电子处方程序连接起来。研究团队由两名医院药剂师、两名护士和来自内科和预防医学系的三名医生组成。
在研究的两个阶段,共纳入了 162 名患者,共重整了 1959 种药物。干预后,无意差异的发生率从 3.5%降至 1.8%(p 值为 0.03)。第一阶段有 23.7%的患者至少有一次无意差异,第二阶段有 14.6%的患者(p 值为 0.20)。遗漏是最常见的无意差异。哮喘患者发生无意差异的风险高 6 倍(OR 6.37,95%CI 1.6-25.5;p 值为 0.009)。
将计算机化工具集成到电子处方程序中对于开展药物重整过程非常有帮助。必须让所有医院工作人员参与这一过程。